The purpose of SMA Europe is to provide a framework to stimulate collaboration and accelerate translational research pathways in SMA and promote patient care.

  1. Scholar Rock Announced Positive Interim Results from Phase 1 Trial of SRK-015 in Healthy Volunteers and Updates on Future Development Plans

    Scholar Rock announced positive interim results from the ongoing Phase 1 clinical trial of its potential muscle-targeted SMA therapy, SRK-015 in healthy adult volunteers. What is SRK-015? SRK-015 is an antibody which inhibits the activities of a muscle protein called myostatin. This protein restricts muscle mass and strength. Scholar Rock believes that by preventing the activation of myostatin, […]